| 1. |
Kawaguchi T, Yamagishi S, Itou M, Okuda K, Sumie S, Kuromatsu R, Sakata M, Abe M, Taniguchi E, Koga H, Harada M, Ueno T, Sata M．Pigment epithelium-derived factor inhibits lysosomal degradation of Bcl-xL and apoptosis in HepG2 cells．Am J Pathol．2010 176: 168-76． |
| 2. |
Kawaguchi T, Taniguchi E, Morita Y, Shirachi M, Tateishi I, Nagata E, Sata M．Association of exogenous insulin or sulphonylurea treatment with an increased incidence of hepatoma in patients with hepatitis C virus infection．Liver Int．2010 30: 479-86． |
| 3. |
Nakamura A, Ueno T, Yagi Y, Okuda K, Ogata T, Nakamura T, Torimura T, Iwamoto H, Sivakuma R, Sata M, Tsutsumi V, Yasuda K, Tomiyasu Y, Obayashi K, Tashiro K, Kuhara S．Human primary cultured hepatic stellate cells can be cryopreserved．Med Mol Morphol．2010 43: 107-15． |
| 4. |
Ide T, Sata M, Sakisaka S, Nakamuta M, Fujiyama S, Mizuta T, Tahara K, Fujisaki K, Komorizono Y, Watanabe H, Morita Y, Tsubouchi H．Peginterferon-alpha-2b plus ribavirin therapy in patients with chronic hepatitis C as assessed by a multi-institutional questionnaire in Japan．Hepatol Res．2010 40: 557-65． |
| 5. |
Arii S, Sata M, Sakamoto M, Shimada M, Kumada T, Shiina S, Yamashita T, Kokudo N, Tanaka M, Takayama T, Kudo M．Management of hepatocellular carcinoma: Report of Consensus Meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009)．Hepatol Res．2010 40: 667-85． |
| 6. |
Takata A, Kuromatsu R, Ando E, Iwamoto H, Fukushima N, Sumie S, Torimura T, Sata M．HCC develops even in the early stage of chronic liver disease in elderly patients with HCV infection．Int J Mol Med．2010 26: 249-56． |
| 7. |
Fukushima N, Kuromatsu R, Arinaga-Hino T, Ando E, Takata A, Sumie S, Nakano M, Kawaguchi T, Ide T, Torimura T, Sata M．Adipocytokine involvement in hepatocellular carcinoma after sustained response to interferon for chronic hepatitis C．Hepatol Res．2010 40: 911-22． |
| 8. |
Ide T, Sata M, Chayama K, Shindo M, Toyota J, Mochida S, Tomita E, Kumada H, Yamada G, Yatsuhashi H, Hayashi N, Ishikawa H, Seriu T, Omata M．Evaluation of long-term entecavir treatment in stable chronic hepatitis B patients switched from lamivudine therapy．Hepatol Int．2010 4: 594-600． |
| 9. |
Kaneko S, Sata M, Ide T, Yamashita T, Hige S, Tomita E, Mochida S, Yamashita Y, Inui Y, Kim SR, Komada N, Mikami T, Satoh S, Morita S, Takaguchi K, Hirashima N, Nishio Y, Watanabe D, Kioka K, Fujiwara K．Efficacy and safety of double filtration plasmapheresis in combination with interferon therapy for chronic hepatitis C．Hepatol Res．2010 40: 1072-81． |
| 10. |
Toyama T, Lee HC, Koga H, Wands JR, Kim M．Noncanonical Wnt11 inhibits hepatocellular carcinoma cell proliferation and migration．Mol Cancer Res．2010 8: 254-65． |
| 11. |
Nakano M, Ando E, Kuromatsu R, Torimura T, Sumie S, Takata A, Fukushima N, Kurogi J, Niizeki T, Iwamoto H, Tanaka M, Sata M．Recent progress in the management of hepatocellular carcinoma detected during a surveillance program in Japan．Hepatol Res．2010 40: 989-96． |
| 12. |
Sakata M, Kawaguchi T, Taniguchi E, Nakayama A, Ishizaki S, Sonaka I, Nakamura T, Itou M, Oriishi T, Abe M, Yanagimoto C, Koga H, Sata M．Oxidized albumin is associated with water retention and severity of disease in patients with chronic liver diseases．e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism．2010 5: e247-e292． |
| 13. |
Sakata M, Kawaguchi T, Taniguchi E, Nakayama A, Ishizaki S, Sonaka I, Maganuma M, Nakamura T, Itou M, Oriishi T, Abe M, Yanagimoto C, Koga H, Harada M, Sakamoto T, Oda, S, Sata M．Redox state of albumin is not associated with colloid osmotic pressure．Mol Med Rep．2010 3: 685-87． |
| 14. |
Fukushima N, Kuroamtsu R, Akiba J, Ando E, Takata A, Sumie S, Nakano M, Nakamura T, Kawahara A, Torimura T, Nakashima O, Okuda K, Yano H, Kage M, Kojiro M, Sata M．Characteristic expression pattern of oxidative stress in livers with cryptogenic hepatocellular carcinoma．Expression and Therapeutic Medicine．2010 1: 809-16． |
| 15. |
Nagamatsu H, Hiraki M, Mizukami N, Yoshida H, Iwamoto H, Sumie S, Torimura T, Sata M．Intra-arterial therapy with cisplatin suspension in lipiodol and 5-fluorouracil for hepatocellular carcinoma with portal vein tumour thrombosis．Aliment Pharmacol Ther．2010 32: 543-50． |
| 16. |
Nagaoka S, Yoshida T, Akiyoshi J, Akiba J, Hisamoto T, Yoshida Y, Abe M, Koga H, Toirimura T, Ueno T, Sata M．The ratio of serum placenta growth factor to soluble vascular endothelial growth factor receptor-1 predicts the prognosis of hepatocellular carcinoma．Oncol Rep．2010 23: 1647-54． |
| 17. |
Fujimoto M, Nakashima O, Komuta M, Miyaaki T, Kojiro M, Yano H. Clinicopathological study of hepatocellular carcinoma with peliotic change. Oncology Lellters. 2010;1(1):17-21. |
| 18. |
Futami K, Ogasawara S, Goto H, Yano H, Furuichi Y. RecQL1 DNA repair helicase: A potential tumor marker and therapeutic target against hepatocellular carcinoma. Int J Mol Med. 2010;25(4):537-45. |
| 19. |
Iwata Y, Okamoto M, Hoshino T, Kitasato Y, Sakazaki Y, Tajiri M, et al. Elevated levels of thioredoxin 1 in the lungs and sera of idiopathic pulmonary fibrosis, non-specific interstitial pneumonia and cryptogenic organizing pneumonia. Intern Med. 2010;49(22):2393-400. |
| 20. |
Nakanuma Y, Zen Y, Harada K, Sasaki M, Nonomura A, Uehara T, et al. Application of a new histological staging and grading system for primary biliary cirrhosis to liver biopsy specimens: Interobserver agreement. Pathol Int. 2010;60(3):167-74. |
| 21. |
Ogasawara S, Komuta M, Nakashima O, Akiba J, Tsuneoka M, Yano H. Accelerated expression of a Myc target gene Mina53 in aggressive hepatocellular carcinoma. Hepatol Res. 2010;40:330-6. |
| 22. |
Yamaguchi R, Tanaka M, Kondo K, Yokoyama T, Kaneko Y, Yamaguchi M, et al. Characteristic morphology of invasive micropapillary carcinoma of the breast: an immunohistochemical analysis. Jpn J Clin Oncol. 2010;40(8):781-7. |
| 23. |
Yamaguchi R, Tanaka M, Yokoyama T, Nonaka H, Kojima K, Terasaki H, et al. Clinicocytopathology of breast cancers with a ring-like appearance on ultrasonography and/or magnetic resonance imaging. Pathol Int. 2010;60(1):22-6. |
| 24. |
Iizuka N, Oka M, Sakaida I, Moribe T, Miura T, Kimura N, Tamatsukuri S, Ishitsuka H, Uchida K, Terai S, Yamashita S, Okita K, Sakata K, Karino Y, Toyota J, Ando E, Ide T, Sata M, Tsunedomi R, Tsutsui M, Iida M, Tokuhisa Y, Sakamoto K, Tamesa T, Fujita Y, Hamamoto Y．Efficient detection of hepatocellular carcinoma by a hybrid blood test of epigenetic and classical protein markers．Clinica Chimica Acta; International Journal of Clinical Chemistry．2011 412: 152-58． |
| 25. |
Kawaguchi T, Nagao Y, Sata M. Section III. General Aspects: Taste Alteration in Palliative Care. Diet and Nutrition in Palliative Care．2011 215-21. |
| 26. |
Kawaguchi T, Shiba N, Takano Y, Maeda T, Sata M. Hybrid training of voluntary and electrical muscle contractions decreased fasting blood glucose and serum interleukin -6 levels in elderly people: a pilot study. Appl Physiol Nutr Metab．2011 36: 276-83. |
| 27. |
Akiba J, Murakami Y, Noda M, Watari K, Ogasawara S, Yoshida T, Kawahara A, Sanada S, Yasumoto M, Yamaguchi R, Kage M, Kuwano M, Ono M, Yano H. N-myc downstream regulated gene1/Cap43 overexpression suppresses tumor growth by hepatic cancer cells through cell cycle arrest at the G0/G1 phase. Cancer Lett．2011 Nov 310(1): 25-34. |
| 28. |
Tonan T, Fujimoto K, Qayyum, A, Azuma S, Ishibashi M, Ueno T, Ono N, Akiyoshi J, Matsushita S, Hayabuchi N, Kawaguchi T, Sata M. Correlation of Kupffer cell function and hepatocyte function in chronic viral hepatitis evaluated with superparamagnetic iron oxide-enhanced magnetic resonance imaging and scintigraphy usingtechnetium- 99m-labelled galactosyl human serum albumin. Exp Ther Med．2011 2: 607-13. |
| 29. |
Ueno T, Nakamura A, Nakayama H, Otabe S, Yuan X, Fukutani T, Iwamoto H, Nakamura T, Koga H, Torimura T, Sata M, Yamada K. Adiponectin suppresses endoplasmic reticulum stress in nonalcoholic steatohepatitis. Exp Ther Med．2011 2: 1035-40. |
| 30. |
Tsedensodnom O, Koga H, Rosenberg SA, Nambotin SB, Carroll JJ, Wands JR, Kim M. Identification of T-cell factor-4 isoforms that contribute to the malignant phenotype of hepatocellular carcinoma cells. Exp Cell Res．2011 317: 920-31. |
| 31. |
Kawaguchi T, Itou M, Taniguchi E, Sakata M, Abe M, Koga H, Oriishi T, Imamura Y, Kato T, Yamada K, Sata M. Serum level of free fatty acids is associated with nocturnal hypoglycemia in cirrhotic patients with HCV infection: a pilot study. Hepatogastroenterol．2011 58: 103-8. |
| 32. |
Itou M, Kawaguchi T, Taniguchi E, Oriishi T, Suetsugu T, Hano R, Yoshihara M, Takishita M, Eguchi M, Ogiwara Y, Otsuyama J, Mutou M, Ibi R, Akiyama R, Ono M, Otsuka M, Nagamatsu A, Tanaka S, Miyakoda K, Emori K, Morita Y, Kumamoto M, Tsuruta O, Sata M. Supplementation before endoscopic therapy for esophageal varices reduces mental stress in patients with liver cirrhosis. Hepatogastroenterol．2011 58: 814-8. |
| 33. |
Yanagimoto C, Harada M, Kumemura H, Abe M, Koga H, Sakata M, Kawaguchi T, Terada K, Hanada S, Taniguchi E, Ninomiya H, Ueno T, Sugiyama T, Sata M. Copper incorporation into ceruloplasmin is regulated by Niemann-Pick C1 protein. Hepatol Res．2011 41: 484-91. |
| 34. |
Kawaguchi T, Kakuma T, Yatsuhashi H, Watanabe H, Saitsu H, Nakao K, Taketomi A, Ohta S, Tabaru A, Takenaka K, Mizuta T, Nagata K, Komorizono Y, Fukuizumi K, Seike M, Matsumoto S, Maeshiro T, Tsubouchi H, Muro T, Inoue O, Akahoshi M, Sata M. Data mining reveals complex interactions of risk factors and clinical feature profiling associated with the staging of non-hepatitis B virus/non-hepatitis C virus-related hepatocellular carcinoma. Hepatol Res．2011 41: 564-71. |
| 35. |
Sakata M, Kawaguchi T, Taniguchi E, Abe M, Koga H, Sata M. Quick and simple method for increasing the reduced albumin fraction in human serum albumin preparations by using stronger neo-minophagen C. Hepatol Res．2011 41: 1120-5. |
| 36. |
Kawaguchi T, Shiba N, Maeda T, Matsugaki T, Takano Y, Itou M, Sakata M, Taniguchi E, Nagata K, Sata M. Hybrid training of voluntary and electrical muscle contractions reduces steatosis, insulin resistance, and IL-6 levels in patients with NAFLD: a pilot study. J Gastroenterol．2011 46: 746-57. |
| 37. |
Iwamoto H, Torimura T, Nakamura T, Hashimoto O, Inoue K, Kurogi J, Niizeki T, Kuwahara R, Abe M, Koga H, Yano H, Kerbel RS, Ueno T, Sata M. Metronomic S-1 chemotherapy and vandetanib: an efficacious and non-toxic treatment for hepatocellular carcinoma. Neoplasia．2011 Mar 13(3): 187-97. |
| 38. |
Taniguchi E, Kawaguchi T, Itou M, Oriishi T, Ibi R, Torii M, Yoshida K, Adachi Y, Otsuka M, Uchida Y, Tanaka S, Takakura M, Sata M. Subjective global assessment is not sufficient to screen patients with defective hepatic metabolism. Nutrition．2011 27: 282-6. |
| 39. |
Kim do Y, Kim JW, Kuromatsu R, Ahn SH, Torimura T, Sherman M. Controversies in surveillance and early diagnosis of hepatocellular carcinoma. Oncology．2011 81(Suppl.1): 56-60. |
| 40. |
Fujimoto K, Kawaguchi T, Nakashima O, Ono J, Ohta S, Kawaguchi A, Tonan T, Ohshima K, Yano H, Hayabuchi N, Izuhara K, Sata M. Periostin, a matrix protein, has potential as a novel serodiagnostic marker for cholangiocarcinoma. Oncol Rep．2011 May 25(5): 1211-6. |
| 41. |
Sumie S, Kawaguchi T, Kuromatsu R, Takata A, Nakano M, Satani M, Yamada S, Niizeki T, Torimura T, Sata M. Total and high molecular weight adiponectin and hepatocellular carcinoma with HCV infection．PLoS One．2011 6: e26840(Page 1-8). |
| 42. |
Fujimoto K, Tonan T, Azuma S, Kage M, Nakashima O, Johkoh T, Hayabuchi N, Okuda K, Kawaguchi T, Sata M, Qayyum A. Evaluation of the mean and entropy of apparent diffusion coefficient values in chronic hepatitis C: correlation with pathologic fibrosis stage and inflammatory activity grade. Radiology．2011 258: 739-48. |
| 43. |
Eslam M, Aparcero R, Kawaguchi T, Del Campo JA, Sata M, Khattab MA, Romero-Gomez M. Meta-analysis: insulin resistance and sustained virological response in hepatitis C. Aliment Pharmacol Ther．2011 34: 297-305. |
| 44. |
Kawaguchi T, Izumi N, Charlton MR, Sata M. Branched-chain amino acids as pharmacological nutrients in chronic liver disease. Hepatology．2011 54: 1063-70. |
| 45. |
Eslam M, Kawaguchi T, Del Campo JA, Sata M, Abo-Elneen Khattab M, Romero-Gomez M. Use of HOMA-IR in hepatitis C. J Viral Hepatitis．2011 18: 675-84. |
| 46. |
Kawaguchi T, Taniguchi E, Itou M, Sakata M, Sumie S, Sata M. Insulin resistance and chronic liver disease. World J Hepatol．2011 3: 99-107. |
| 47. |
Kawaguchi T, Kaji R, Horiuchi H, Shirono T, Ishida Y, Okabe Y, Itou M, Mitsuyama K, Akiba J, Nakashima O, Yano H, Kage M, Harada M, Sakisaka S, Sata M. Development of intrahepatic cholangiocarcinoma after a 14-year follow-up of a patient with primary sclerosing cholangitis and ulcerative colitis. Hepatol Res．2011 41: 1253-9. |
| 48. |
Yamaguchi R, Tanaka M, Mizushima Y, Hirai Y, Yamaguchi M, Kaneko Y, Terasaki H, Yokoyama T, Nonaka Y, Yano H. Myxomatous fibroadenoma of the breast: correlation with clinicopathologic and radiologic features. Hum Pathol. 2011 Mar 42(3):419-23. |
| 49. |
Taira T, Kawahara A, Yamaguchi T, Abe H, Ishida Y, Okabe Y, Naito Y, Yano H, Kage M. Morphometric image analysis of pancreatic disease by ThinPrep liquid-based cytology. Diagn Cytopathol. 2011 May 4 (in press). |
| 50. |
Naito Y, Okabe Y, Nagayama M, Nishinakagawa T, Taira T, Kawahara A, Hattori S, Machida K, Ishida Y, Kaji R, Mikagi K, Kinoshita H, Yasumoto M, Akiba J, Kage M, Nakashima M, Ohshima K, Yano H. Accuracy of differential diagnosis for pancreatic cancer is improved in the combination of RCAS1 and CEA measurements and cytology in pancreatic juice. Med Mol Morphol. 2011 Jun; 44(2): 86-92. |
| 51. |
Yamaguchi R, Tanaka M, Mizushima Y, Hirai Y, Yamaguchi M, Terasaki H, Yokoyama T, Tsuchiya S, Nakashima O, Yano H. "High-grade" central acellular carcinoma and matrix-producing carcinoma of the breast: correlation between ultrasonographic findings and pathological features. Med Mol Morphol. 2011 Sep; 44(3):151-7. |
| 52. |
Torimura T, Ueno T, Taniguchi E, Masuda H, Iwamoto H, Nakamura T, Inoue K, Hashimoto O, Abe M, Koga H, Barresi V, Nakashima E, Yano H, Sata M. Interaction of endothelial progenitor cells expressing cytosine deaminase in tumor tissues and 5-fluorocytosine administration suppresses growth of 5-fluorouracil-sensitive liver cancer in mice. Cancer Sci．2012 Mar; 103(3): 542-8. |
| 53. |
Nakamura T, Torimura T, Iwamoto H, Masuda H, Naitou M, Koga H, Abe M, Hashimoto O, Tsutsumi V, Ueno T, Sata M. Prevention of liver fibrosis and liver reconstitution of DMN-treated rat liver by transplanted EPCs. Eur J Clin Invest．2012 42: 717-28. |
| 54. |
Abe M, Koga H, Yoshida T, Masuda H, Iwamoto H, Sakata M, Hanada S, Nakamura T, Taniguchi E, Kawaguchi T, Yano H, Torimura T, Ueno T, Sata M. Hepatitis C virus core protein upregulates the expression of vascular endothelial growth factor via the nuclear factor-κB/hypoxia-inducible factor-1α axis under hypoxic conditions. Hepatol Res．2012 Jun 42(6): 591-600. |
| 55. |
Koga H, Selvendiran K, Sivakumar R, Yoshida T, Torimura T, Ueno T, Sata M. PPARγ potentiates anticancer effects of gemcitabine on human pancreatic cancer cells. Int J Oncol．2012 40(3): 679-85. |
| 56. |
Nakamura T, Tsutsumi V, Torimura T, Naitou M, Iwamoto H, Masuda Y, Hashimoto O, Koga H, Abe M, Ii M, Kawamoto A, Asahara T, Ueno T, Sata M. Human peripheral blood CD34-positive cells enhance therapeutic regeneration of chronically injured liver in nude rats. J Cell Physiol．2012 227: 1538-52. |
| 57. |
Hino-Arinaga T, Ide T, Kuromatsu R, Miyajima I, Ogata K, Kuwahara R, Hisamochi A, Torimura T, Sata M; Autoimmune Hepatitis Study Group. Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1. J Gastroenterol．2012 47: 569-76. |
| 58. |
Niizeki T, Sumie S, Torimura T, Kurogi J, Kuromatsu R, Iwamoto H, Aino H, Nakano M, Kawaguchi A, Kakuma T, Sata M. Serum vascular endothelial growth factor as a predictor of response and survival in patients with advanced hepatocellular carcinoma undergoing hepatic arterial infusion chemotherapy. J Gastroenterol．2012 47: 686-95. |
| 59. |
Hanada S, Harada M, Abe M, Akiba J, Sakata M, Kwan R, Taniguchi E, Kawaguchi T, Koga H, Nagata E, Ueno T, Sata M. Aging modulates susceptibility to mouse liver Mallory-denk body formation. J Histochem Cytochem．2012 60: 475-83. |
| 60. |
Tonan T, Fujimoto K, Qayyum A, Kawaguchi T, Kawaguchi A, Nakashima O, Okuda K, Hayabuchi N, Sata M. Quantification of Hepatic Iron Concentration in Chronic Viral Hepatitis: Usefulness of T2-weighted Single-Shot Spin-Echo Echo-Planar MR Imaging. PLoS One．2012 7: e33868(Page 1-7). |
| 61. |
Koga H, Tsedensodnom O, Tomimaru Y, Walker EJ, Lee HC, Kim KM, Yano H, Wands JR, Kim M. Loss of the SxxSS motif in a human T-dell factor-4 isoform confers hypoxia resistance to liver cancer: An oncogenic switch in Wnt signaling. PLoS One．2012 7: e39981(Page 1-14). |
| 62. |
Kawaguchi T, Taniguchi E, Sata M. Motor vehicle accidents: How should cirrhotic patients be managed ? World J Gastroenterol．2012 18: 2597-9. |
| 63. |
Watanabe T, Itabashi M, Shimada Y, Tanaka S, Ito Y, Ajioka Y, Hamaguchi T, Hyodo I, Igarashi M, Ishida H, Ishiguro M, Kanemitsu Y, Kokudo N, Muro K, Ochiai A, Oguchi M, Ohkura Y, Saito Y, Sakai Y, Ueno H, Yoshino T, Fujimori T, Koinuma N, Morita T, Nishimura G, Sakata Y, Takahashi K, Takiuchi H, Tsuruta O, Yamaguchi T, Yoshida M, Yamaguchi N, Kotake K, Sugihara K; Japanese Society for Cancer of the Colon and Rectum．Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer．Int J Clin Oncol．2012 17: 1-29. |
| 64. |
Kawaguchi T, Ide T, Itou M, Suetsugu M, Yoshioka S, Sakata M, Taniguchi E, Oriishi T, Sumie S, Tsuruta O, Sata M. Ischaemic colitis during interferon treatment for chronic hepatitis C: report of two cases and literature review. J Viral Hepatitis．2012 19: e220-e224. |
| 65. |
Yamaguchi R, Tsuchiya S, Koshikawa T, Yokoyama T, Mibuchi K, Nonaka Y, Ito S, Higuchi H, Nagao M, Watanabe J, Higaki K, Kage M, Yano H. Comparison of the accuracy of breast cytological diagnosis at seven institutions in southern Fukuoka Prefecture, Japan. Jpn J Clin Oncol. 2012 Jan 42(1): 21-8. |
| 66. |
Yamaguchi R, Tanaka M, Yokoyama T, Nonaka Y, Mizushima Y, Kawahara A, Yoshida T, Ito T, Yamaguchi M, Kage M, Yano H. Cytological features of myxomatous fibroadenoma of the breast. Diagn Cytopathol. 2012 Apr 40(4): 316-20. |
| 67. |
Komuta M, Govaere O, Vandecaveye V, Akiba J, Van Steenbergen W, Verslype C, Laleman W, Pirenne J, Aerts R, Yano H, Nevens F, Topal B, Roskams T. Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes. Hepatology. 2012 Jun 55(6): 1876-88. |
| 68. |
Yamaguchi R, Tanaka M, Tse GM, Yamaguchi M, Terasaki H, Akiba J, Naito Y, Mizushima Y, Yano H. Pure flat epithelial atypia is uncommon in subsequent breast excisions for atypical epithelial proliferation. Cancer Sci. 2012 Aug 103(8): 1580-5. |
| 69. |
Yamaguchi R, Tanaka M, Kondo K, Yokoyama T, Maeda I, Tsuchiya S, Yamaguchi M, Takahashi R, Ogata Y, Abe H, Akiba J, Nakashima O, Kage M, Yano H. Immunohistochemical study of metaplastic carcinoma and central acellular carcinoma of the breast: central acellular carcinoma is related to metaplastic carcinoma. Med Mol Morphol. 2012 Dec 45(1): 14-21. |
| 70. |
Fujiwara M, Kwok S, Yano H, Pai RK. Arginase-1 is a more sensitive marker of hepatic differentiation than HepPar-1 and glypican-3 in fine-needle aspiration biopsies. Cancer Cytopathol. 2012 Mar 20 (in press). |
| 71. |
Yamaguchi R, Tanaka M, Yano A, Tse GM, Yamaguchi M, Koura K, Kanomata N, Kawaguchi A, Akiba J, Naito Y, Ohshima K, Yano H. Tumor-infiltrating lymphocytes are important pathologic predictors for neoadjuvant chemotherapy in patients with breast cancer. Hum Pathol. 2012 Apr 17 (in press). |
| 72. |
Taniguchi E, Kawaguchi T, Otsuka M, Uchida Y, Nagamatsu A, Itou M, Oriishi T, Ishii K, Imanaga M, Suetsugu T, Otsuyama J, Ibi R, Ono M, Tanaka S, Sata M. Nutritional assessments for ordinary medical care in patients with chronic liver disease. Hepatol Res. 2012 (in press). |
| 73. |
Miyajima I, Kawaguchi T, Fukami A, Nagao Y, Adachi H, Sasaki S, Imaizumi T, Sata M. Chronic HCV infection was associated with severe insulin resistance and mild atherosclerosis: a population-based study in an HCV hyperendemic area. J Gastroenterol． 2012 (in press). |
| 74. |
Sakata M, Kawahara A, Kawaguchi T, Akiba J, Taira T, Taniguchi E, Abe M, Koga H, Kage M, Sata M. Decreased expression of insulin and increased expression of pancreatic transcription factor PDX-1 in islets in patients with liver cirrhosis: a comparative investigation using human autopsy specimens. J Gastroenterol．2012 Jul 12 [Epub ahead of print] (in press). |
| 75. |
Toyoda H, Kumada T, Shimada N, Takaguchi K, Ide T, Sata M, Ginba H, Matsuyama K, Izumi N．Significance of a reduction in HCV RNA levels at 4 and 12 weeks in patients infected with HCV genotype 1b for the prediction of the outcome of combination therapy with peginterferon and ribavirin．BMC Infect Dis．2012 12: No.324. |
| 76. |
Inoue K, Torimura T, Nakamura T, Iwamoto H, Masuda H, Abe M, Hashimoto O, Koga H, Ueno T, Yano H, Sata M．Vandetanib, an inhibitor of VEGF receptor-2 and EGF receptor, suppresses tumor development and improves prognosis of liver cancer in mice．Clin Cancer Res．2012 18: 3924-33. |
| 77. |
Otsuka M, Uchida Y, Kawaguchi T, Taniguchi E, Kawaguchi A, Kitani S, Itou M, Oriishi T, Kakuma T, Tanaka S, Yagi M, Sata M．Fish to meat intake ratio and cooking oils are associated with hepatitis C virus carriers with persistently normal alanine aminotransferase levels．Hepatol Res．2012 42: 982-9. |
| 78. |
Abe K, Katsushima F, Kanno Y, Takahashi A, Yokokawa J, Ohira H, Arinaga T, Ide T, Nishimura J, Inoue M, Seike M, Imazeki F, Yokosuka O, Sata M．Clinical features of cirrhosis in Japanese patients with type I autoimmune hepatitis．Intern Med．2012 51: 3323-28. |
| 79. |
Okusaka T, Kasugai H, Ishii H, Kudo M, Sata M, Tanaka K, Shioyama Y, Chayama K, Kumada H, Yoshikawa M, Seki T, Saito H, Hayashi N, Shiratori K, Okita K, Sakaida I, Honda M, Kusumoto Y, Tsutsumi T, Sakata K．A randomized phase II trial of intra-arterial chemotherapy using SM-11355 (Miriplatin) for hepatocellular carcinoma．Invest New Drugs．2012 30: 2015-25. |
| 80. |
Kawaguchi T, Komori A, Seike M, Fujiyama S, Watanabe H, Tanaka M, Sakisaka S, Nakamuta M, Sasaki Y, Oketani M, Hattori T, Katsura K, Sata M．Efficacy and safety of eltrombopag in Japanese patients with chronic liver disease and thrombocytopenia: a randomized, open-label, phase II study．J Gastroenterol．2012 47: 1342-51. |
| 81. |
Nakano M, Tanaka M, Kuromatsu R, Nagamatsu H, Sakata K, Matsugaki S, Kajiwara M, Fukuizumi K, Tajiri N, Matsukuma N, Sakai T, Ono N, Yano Y, Koga H, Kurogi J, Takata A, Sumie S, Satani M, Yamada S, Niizeki T, Aino H, Iwamoto H, Torimura T, Sata M．Efficacy, safety, and survival factors for Sorafenib treatment in Japanese patients with advanced hepatocellular carcinoma．Oncology．2012 84: 108-14. |
| 82. |
Nagao Y, Kawaguchi T, Ide T, Sata M．Effect of branched-chain amino acid-enriched nutritional supplementation on interferon therapy in Japanese patients with chronic hepatitis C virus infection: a retrospective study．Virol J．2012 9: 282. |
| 83. |
Itou M, Kawaguchi T, Taniguchi E, Oriishi T, Sata M．Dipeptidyl peptidase IV inhibitor improves insulin resistance and steatosis in a refractory nonalcoholic fatty liver disease patient: a case report．Case Rep Gastroenterol．2012 6: 538-44. |
| 84. |
Kawaguchi T, Torimura T, Takata A, Satomi S, Sata M．Valine, a branched-chain amino acid, reduced HCV viral load and led to eradication of HCV by interferon therapy in a decompensated cirrhotic patient．Case Rep Gastroenterol．2012 6: 660-67. |
| 85. |
Sakamoto M, Nakamura T, Torimura T, Iwamoto H, Masuda H, Koga H, Abe M, Hashimoto O, Ueno T, Sata M．Transplantation of endothelial progenitor cells ameliorates vascular dysfunction and portal hypertension in carbon tetrachloride-induced rat liver cirrhotic model．J Gastroenterol Hepatol．2013 28: 168-78. |
| 86. |
Toyoda H, Kumada T, Shimada N, Takaguchi K, Ide T, Sata M, Ginba H, Matsuyama K, Izumi N．Baseline factors and early viral response (week 4) to antiviral therapy with peginterferon and ribavirin for predicting sustained virologic response in patients infected with hepatitis C virus genotype 1: A multicenter study．J Med Virol．2013 85: 65-70. |
| 87. |
Iwao T, Sakai K, Sata M. Postprandial serum C-peptide is a useful parameter in the prediction of successful switching to liraglutide monotherapy from complex insulin therapy in Japanese patients with type 2 diabetes. J Diabetes Complicat. 2012 Aug 2. [Epub ahead of print](in press). |
| 88. |
Yasumoto M, Hamabashiri M, Akiba J, Ogasawara S, Naito Y, Taira T, Nakayama M, Daicho A, Yamasaki F, Shimamatsu K, Ishida Y, Kaji R, Okabe Y, Nakashima O, Ohshima K, Nakashima M, Sata M, Yano H. The utility of a novel antibody in the pathological diagnosis of pancreatic acinar cell carcinoma. J Clin Pathol. 2012 Apr;65(4):327-32. |
| 89. |
Yamaguchi R, Maeshiro K, Ellis IO, Rakha EA, Taguchi J, Shima I, Kamei H, Suzuki M, Imamura M, Nakayama G, Yano H. Infiltrative epitheliosis of the breast. J Clin Pathol. 2012 Mar; 65(8): 766-68. |
